Drugs / Olanzapine, Omega 3, Vitamin E+C
Olanzapine, Omega 3, Vitamin E+C
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00211562 Comparator | Oct 2005 → Jan 2006 | schizophrenia | Augusta University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Olanzapine, Omega 3, Vitamin E+C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00211562 ↗ |
| Modality | Other / unclassified | “adding vitamins and fats (nutritional supplements) to a diet” NCT00211562 ↗ |